Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Changde Jizhi Biological Technology Co. Ltd. has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 5 distinct examiners and 5 distinct art units, indicating that each pending matter is distributed across a separate examination channel in the available record. Counsel should use strong docket discipline and maintain separate technical, claim, and prior-art analyses.
AXTELL, ASHLEY is the busiest examiner, with 1 pending matter. This assignment represents one part of the broader prosecution record, which is handled by other examiners and art units. Portfolio management should coordinate terminology and strategic objectives while allowing each response to address its own biotechnology and pharmaceutical examination issues.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AXTELL, ASHLEY | 1 | 13.2% | +25.7% |
| BERRIOS, JENNIFER A | 1 | 37.1% | +49.3% |
| ARCORIA, PAUL JOSEPH | 1 | 100.0% | +0.0% |
| JONES-FOSTER, ERICA NICOLE | 1 | 49.4% | +44.0% |
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18391872 | COLD COMPRESS SPRAY FOR RELIEVING GOUT AND PREPARATION METHOD THEREOF | ARCORIA, PAUL JOSEPH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18413097 | HEALTH CULTIVATION WINE AND PREPARATION METHOD THEREOF | AXTELL, ASHLEY | 34d |
| 18405886 | MULTI-VITAMIN FOR ADJUVANT TREATMENT OF AIDS, AND PREPARATION METHOD AND APPLICATION METHOD THEREOF | BERRIOS, JENNIFER A | — |
| 18534574 | BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF | JONES-FOSTER, ERICA NICOLE | — |
| 18467745 | MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF | BOECKELMAN, JACOB A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18413097 | HEALTH CULTIVATION WINE AND PREPARATION METHOD THEREOF | AXTELL, ASHLEY | 34d |
| 18405886 | MULTI-VITAMIN FOR ADJUVANT TREATMENT OF AIDS, AND PREPARATION METHOD AND APPLICATION METHOD THEREOF | BERRIOS, JENNIFER A | — |
| 18534574 | BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF | JONES-FOSTER, ERICA NICOLE | — |
| 18467745 | MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF | BOECKELMAN, JACOB A | — |
| Art Unit | Apps |
|---|---|
| 1792 | 1 |
| 1633 | 1 |
| 1621 | 1 |
| 1656 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18413097 | HEALTH CULTIVATION WINE AND PREPARATION METHOD THEREOF | AXTELL, ASHLEY | 1792 | §112 | Non-Final OA | 34d | Pending | Jan 16, 2024 |
| 18405886 | MULTI-VITAMIN FOR ADJUVANT TREATMENT OF AIDS, AND PREPARATION METHOD AND APPLICATION METHOD THEREOF | BERRIOS, JENNIFER A | 1633 | §103§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18391872 | COLD COMPRESS SPRAY FOR RELIEVING GOUT AND PREPARATION METHOD THEREOF | ARCORIA, PAUL JOSEPH | 1621 | §103 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18534574 | BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF | JONES-FOSTER, ERICA NICOLE | 1656 | §101§103§112 | Final Rejection | — | Pending | Dec 09, 2023 |
| 18467745 | MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF | BOECKELMAN, JACOB A | 1655 | §102§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChangde Jizhi Biological Technology Co. Ltd. has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Ashley Axtell has the most, with 1 of Changde Jizhi Biological Technology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
